CD276 and breast carcinoma: Moreover, it has been reported that miR-665 directly target CD276 by associating with the CD276 3′-UTR region and mediated the downregulation of CD276 in breast cancer, which may provide a mechanism for miRNA to participate in the regulation of immune-related genes [88].